The FDA also explains that the drugs could cause weight loss, and that "weight loss offers no benefit to a pregnant patient and may cause fetal harm." The FDA recommends that people discontinue treatment at least two months before they plan to become pregnant
Because synthetic GLP-1 doesn't break down as easily as the real thing, it can "help create the feeling that you just ate dinner, so you don't want more food," according to Weill Cornell Medicine obesity expert Louis Aronne, MD, whose most recent research on the drugs appeared in the Journal of the American Medical Association in November 2024
Interestingly, the public market does not yet acknowledge the benefit of the merger, with Teladoc and Livongo ending the trading day on August 5, 2020, 19.01% and 11.40% lower than the day before, respectively
Patients should request a medical review if their weight has remained stable for 4-8 weeks or longer despite adherence to lifestyle modifications and medication
Sterile process Lyophilised under sterile clean-room conditions
Hers is also not available in every state for GLP-1 prescriptions specifically
